Full history for every metric is available with a Kvantra account
Eargo, Inc. (EAR)
Key financial summary
Financials in USD| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 7 | 23 | 33 | 69 | 32 | 37 | 41 |
| Operating profit | $m | -112 | -90 | |||||
| Net profit | $m | -25 | -34 | -44 | -30 | -158 | -157 | -108 |
| EPS reported | $ | -39.68 | -7.52 | |||||
| Operating cashflow per share | $ | -29.56 | -29.56 | |||||
| Capex per share | $ | 0.78 | 0.78 | |||||
| FCF per share | $ | -30.34 | -30.34 | |||||
| Free cash flow | $m | -120 | -76 | |||||
| Net debt | $m | -95 | -46 | |||||
| Book value equity | $m | 101 | 45 | |||||
| Book value per share | $ | 25.41 | 2.17 | |||||
| Number of shares | m | 3.97 | 20.76 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 0.05 | 1.18 | |||||
| P/S LTM | x | 0.12 | 1.30 | |||||
| P/FCF LTM | x | -0.04 | -0.70 | |||||
| EV/EBITDA LTM | x | 0.60 | -0.07 | |||||
| EV/Sales LTM | x | -2.42 | 0.18 | |||||
| Earnings Yield LTM | % | -3450.9% | -1544.2% | |||||
| FCF Yield | % | -2638.0% | -142.27% | |||||
| Quality | ||||||||
| ROE | % | -156.15% | -185.26% | |||||
| ROIC | % | -104.01% | -104.01% | |||||
| Operating margin | % | -300.04% | -300.04% | |||||
| Gross margin | % | 38.28% | 38.28% | |||||
| FCF/Sales | % | -323.21% | -323.21% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +15.96% | +22.45% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -18.24 | -9.92 | |||||
| Net Debt/EBITDA | x | 0.63 | 0.63 | |||||
| EBIT/Net interest | x | -203.57 | -203.57 | |||||
| Net debt/market cap | % | -2073.7% | -86.25% | |||||
| Net debt/Equity | x | -0.94 | -1.02 | |||||
| Gross debt/equity | x | 0.07 | 0.17 | |||||
Company overview
Eargo, Inc., a medical device firm, strives to improve the quality of life for individuals experiencing hearing impairment across the United States. The company focuses on developing and distributing hearing aids, utilizing both direct-to-consumer and extensive omni-channel sales approaches. Founded in 2010, the organization initially operated as Aria Innovations, Inc., before officially changing its name to Eargo, Inc. in November 2014. Its primary corporate hub is located in San Jose, California.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Eargo, Inc. (EAR)
Eargo, Inc., a medical device firm, strives to improve the quality of life for individuals experiencing hearing impairment across the United States. The company focuses on developing and distributing hearing aids, utilizing both direct-to-consumer and extensive omni-channel sales approaches. Founded in 2010, the organization initially operated as Aria Innovations, Inc., before officially changing its name to Eargo, Inc. in November 2014. Its primary corporate hub is located in San Jose, California.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free